ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 908,62
-0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Olink Holding AB (OLK)

  7. Olink Holding AB (OLK) Actualités

OLK Olink Holding AB

23,93
-0,02 (-0,08%)
17 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Olink Holding AB OLK NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,02 -0,08% 23,93 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
23,90 23,75 23,97 23,93 23,95
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/5/202412:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202412:00GLOBEOlink reports first quarter 2024 financial results
19/4/202422:05GLOBEReport from the Annual General Meeting of Olink Holding AB..
02/4/202414:00GLOBEOlink® Insight Unveils Open-access Map of the Human..
25/3/202413:00GLOBEOlink reports fourth quarter and full year 2023 financial..
15/3/202413:00GLOBENotice to attend the Annual General Meeting of Olink Holding..
08/3/202414:00GLOBEOlink announces change of date for Annual General Meeting
06/3/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202422:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
20/2/202422:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/1/202422:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
22/12/202322:47EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/12/202322:45EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/11/202313:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202313:00GLOBEOlink reports third quarter 2023 financial results
13/11/202323:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
06/11/202302:00GLOBENovogene Asia Pacific Middle East and Africa adopts Olink®..
31/10/202316:36EDGAR2Form SC 14D9 - Solicitation, recommendation statements
25/10/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202323:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202300:40BWThermo Fisher Scientific prépare l'acquisition d'Olink,..
18/10/202300:39BWThermo Fisher Scientific übernimmt Olink, ein führendes..
17/10/202323:28EDGAR2Form SC14D9C - Written communication relating to third party..
17/10/202316:16DJNOlink Holding Shares Soar on Takeover by Thermo Fisher
17/10/202315:01DJNThermo Fisher to Buy Olink in $3.1 Billion Deal
17/10/202314:19BWThermo Fisher Scientific to Acquire Olink, a Leader in..
05/10/202322:25GLOBELandmark studies utilizing Olink® Explore technology signal..
19/9/202309:00GLOBEAnnouncing the Olink® Target 48 Mouse Cytokine Panel – the..
12/9/202317:00GLOBEEurofins Genomics adopts Olink® technology to advance..
29/8/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202314:00GLOBEOlink to participate in September investor events
18/8/202302:07EDGAR2Form 144 - Report of proposed sale of securities
09/8/202313:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/8/202313:00GLOBEOlink reports second quarter 2023 financial results
08/8/202314:00GLOBEBaylor College of Medicine Human Genome Sequencing Center..
13/7/202314:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202314:00GLOBEOlink to report second quarter 2023 financial results on..
12/7/202315:00GLOBEAnnouncing Olink® Explore HT – A New Era in Proteomics
28/6/202314:00GLOBERevealing the secrets of the human proteome with Olink®..
25/5/202314:00GLOBEOlink to participate in June investor events

Dernières Valeurs Consultées

NASDAQ
OLK
Olink Holding AB
BIT
S32143
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés